Active Ingredient(s): Isavuconazonium Sulfate
FDA Approved: * March 6, 2015
Pharm Company: * ASTELLAS
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cresemba Overview

Isavuconazonium sulfate, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis.[2][3][4][5] Isavuconazonium is a prodrug of isavuconazole. Contents 1 Medical uses 2 Contraindications 3 Side effects 4 Interactions 5 Pharmacology 6 Chemistry 7 History 8 References 9 External links Medical uses Isavuconazonium is used to tre...

Read more Cresemba Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cresemba Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Isavuconazonium Sulfate
  • Capsule: 186mg
  • Injection: 372mg
  • Powder: 372mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cresemba: (3 results)

Sorted by National Drug Code
  • 0469-0320 Cresemba 186 mg Oral Capsule by Astellas Pharma Us, Inc.
  • 0469-0420 Cresemba 74.4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us, Inc.
  • 0469-0520 Cresemba 186 mg Oral Capsule by Astellas Pharma Us, Inc.

Other drugs which contain Isavuconazonium Sulfate or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA